Essential Partners’s Jade Biosciences JBIO Stock Holding History

Essential Partners’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$56	Sell	4 -4	-50%	-$80	﹤0.01%	2757
2026 Q2	$178	Buy	+8	New	+$167	﹤0.01%	2659

Other funds holding JBIO

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners's JBIO Position: Q3 2026 in Review

Essential Partners reduced its Jade Biosciences (JBIO) stake by 50% in Q3 2026, selling an estimated $80 and leaving 4 shares worth $56. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

Essential Partners first reported a position in JBIO in Q2 2026 and has held it in 2 quarters since. The position peaked at $178 in Q2 2026. 5 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

Essential Partners held 4 shares of Jade Biosciences worth $56 as of Q3 2026.
Essential Partners sold 4 Jade Biosciences shares in Q3 2026, an estimated $80.
Jade Biosciences made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2757 holding.
Essential Partners first reported a position in Jade Biosciences in Q2 2026 and has held it in 2 quarters since.
Essential Partners's Jade Biosciences position peaked at $178 in Q2 2026.
5 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.